SEATTLE–(BUSINESS WIRE)–#BiopharmaceuticalContractManufacturing–According to Coherent Market Insights, the Latin America Pharmaceutical Products CMO Market is estimated to be valued at US$ 15,173.6 million in 2020 and is expected to exhibit a CAGR of 14.7% over the forecast period (2020-2027).
Key Trends and Analysis of the Latin America Pharmaceutical Products CMO Market:
Increase in incidence of cancer disease in the Latin America is expected to drive the Latin America pharmaceutical product CMO market during the forecast period. For instance, in 2018, according to the World Health Organization report, around 1,044,017 new cancer cases were diagnosed in Latin America.
Moreover, increase in pharmaceutical spending contributes to development of more comprehensive healthcare systems in Brazil. Brazil implemented one of the largest universal healthcare systems in the world – the Sistema Único de Saúde (Unified Health System) for improving healthcare system in the country.
Furthermore, integration of public and private healthcare sector in Latin America may lead to revival of a weak sector in the region, thereby driving growth of the market.
Buy-Now this Research Report for detailed market insights @ https://www.coherentmarketinsights.com/insight/buy-now/3933
Key Market Takeaways:
The Latin America pharmaceutical products CMO market is expected to exhibit a CAGR of 14.7% over the forecast period. Owing to increasing government initiatives such as the Growth Acceleration Program and the Greater Brazil Plan to increase domestic pharmaceutical production in Brazil, along with increasing Foreign Direct Investment in the region are major factors driving the market growth in the region during the forecast period. For instance in 2018, according to the United Nations Conference on Trade and Development, Mexico received around US$ 32 Bn in FDI (Foreign Direct Investment) and nearly half was utilized by the manufacturing sector.
Competitive Landscape:
Key players operating in the Latin America Pharmaceutical Products CMO Market include BASF SE, Bayer AG, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, Pfizer, Inc., Pisa Farmacéutica, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, Ferring Pharmaceuticals, Inc., and Landsteiner Scientific.
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/3933
Market Segmentation:
Related Market Intelligence Reports:
Contract Pharmaceutical Manufacturing Market, by Service Type (Contract Manufacturing Organization (CMO) (API Manufacturing, Final Dosage Form Manufacturing and Packaging), Contract Research Organization (CRO) (Drug Discovery, Preclinical Studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management and Protocol Development), by Molecule Type (Small Molecules and Large Molecules), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Cytotoxic Drugs Contract Manufacturing Market, by Production Scale (Industrial Scale, Pilot Scale, and Laboratory Scale), by Form (Liquid, and Solid), by Product Type (Oral and Intravenous), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027
Vaccine Contract Manufacturing Market – by Service Type (Fill-Finish and Bulk Product), by Vaccine Type (Subunit Vaccines, Live Attenuated Vaccines, and Others), and by Product Type (Single Vaccine and Combination Vaccine) – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Read more: https://www.coherentmarketinsights.com/ongoing-insight/vaccine-contract-manufacturing-market-1083
Biopharmaceutical Contract Manufacturing Market, By Contract Type (Active Pharmaceutical Ingredient (API) and Fill-And-Finished), By Product Type (Interferon, Monoclonal Antibodies, Protein, Vaccines, Vitamins and Others), By Therapeutic Applications (Oncology, Cardiovascular Diseases, and Others) – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2026 – 2026
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.
Contacts
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter
LCF Georgia's Civic Participation Fellowship Program: 21 Fellows Trained in Civic Engagement and Community OrganizingATLANTA,…
Safe Haven for Youth and Young AdultsHAYWARD, CA / ACCESSWIRE / June 25, 2024 /…
OAK BROOK, Ill., June 25, 2024 /PRNewswire/ -- Lions International celebrated several milestones during the…
Dr. Anthony Yanni publishes a wide-ranging case for patient-centered healthcare delivery and treatment development—a "long-overdue…
NEW YORK, June 25, 2024 /PRNewswire/ -- The Informatics Technology for Cancer Research (ITCR) program…
World's First AI to Detect 35 Cardiac Determinations, Including Heart Attack, Using a Reduced Leadset…
